Abstract
Primary sclerosing cholangitis (PSC) is a chronic, progressive, cholestatic liver disease with no known cure. It is a serious condition, and diagnosis comes with an increased risk of developing cancer of the gallbladder, bile ducts or liver. Symptoms can include fatigue and jaundice, although the disease can be initially asymptomatic. Patients are at risk of deficiencies in fat-soluble vitamins. PSC is also associated with ulcerative colitis, and patients with a dual diagnosis will have an increased risk of developing bowel cancer. In addition, patients can develop fatal complications from colitis or liver failure. As such, primary sclerosing cholangitis can be characterised as a pre-malignant condition. In view of this, it is essential that patients undergo regular surveillance to observe and rapidly treat any developing complications.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
